Filing search / Phathom Pharmaceuticals, Inc. / "Safety"

Search information

Phathom Pharmaceuticals, Inc.

Companies

"Safety"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

75 results

Newest first Best match first

10-K

2024 FY

PHAT Phathom Pharmaceuticals, Inc.

Annual report

the efficacy and safety of vonoprazan for the daily treatment of adults with Non-Erosive GERD, both doses of vonoprazan (10 mg and 20 mg) met the primary … the ideal profile for an OTC product because of the potential for rapid symptom relief and a well-tolerated safety profile. We plan to explore the economics

6 Mar 25

8:05am

10-Q

2024 Q3

PHAT Phathom Pharmaceuticals, Inc.

Quarterly report

on, among other factors, status of regulatory approval, information regarding safety, efficacy and expectations relating to commercial sales … -NERD-301, a Phase 3 study evaluating the safety and efficacy of vonoprazan for the daily treatment of adults with Non-Erosive GERD, and in August

7 Nov 24

4:05pm

10-Q

2024 Q2

PHAT Phathom Pharmaceuticals, Inc.

Quarterly report

, status of regulatory approval, information regarding safety, efficacy and expectations relating to commercial sales and recoverability of costs … positive topline results from PHALCON-NERD-301, a Phase 3 study evaluating the safety and efficacy of vonoprazan for the daily treatment of adults

8 Aug 24

4:05pm

10-K/A

2023 FY

PHAT Phathom Pharmaceuticals, Inc.

Annual report (amended)

of capitalizing inventory costs for a product based on, among other factors, status of regulatory approval, information regarding safety, efficacy

14 Jun 24

4:05pm

10-Q/A

2024 Q1

PHAT Phathom Pharmaceuticals, Inc.

Quarterly report (amended)

factors, status of regulatory approval, information regarding safety, efficacy and expectations relating to commercial sales and recoverability of costs

14 Jun 24

4:05pm

10-Q

0fg 9p0l2xpo0ip

Quarterly report

9 May 24

4:06pm

10-K

wm4i3k1b5u4l4jxzz

Annual report

7 Mar 24

4:01pm

Amendments to Articles of Incorporation or Bylaws

Amendments to Articles of Incorporation or Bylaws

9 Nov 23

8:05am

Phathom Pharmaceuticals Reports Third Quarter 2023 Results and Recent Business Updates

Phathom Pharmaceuticals Reports Second Quarter 2023 Results

10 Aug 23

8:06am

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Filing search / Phathom Pharmaceuticals, Inc. / "Safety"

75 results

Top filers

Top filing types

Recent filing years